Histamine H2-receptor antagonists stimulate proliferation but not migration of human gastric mucosal cells in vitro.
Gastric mucosal cell migration and proliferation are crucial events in the repair of gastric mucosal erosions. This study was designed to test the hypothesis that the H2 blockers roxatidine and ranitidine might stimulate migration and proliferation of gastric mucous cells derived from a human well-differentiated gastric adenocarcinoma cell line (MKN 28 cells) in vitro, in conditions independent of systemic factors and of acid inhibition. Confluent monolayers of MKN 28 cells were wounded with a razor blade and were then incubated with roxatidine or ranitidine. The number of cells migrating to the damaged area was determined 24 hr later. Cell proliferation was assessed by means of [3H] thymidine uptake and cell counts after incubation with roxatidine or ranitidine. Neither H2 antagonist significantly stimulated cell migration. On the other hand, cell proliferation was dose-dependently and significantly enhanced by incubation with roxatidine and ranitidine. Exogenous administration of TGF-alpha significantly stimulated MKN 28 cell division. However, incubation with roxatidine or ranitidine did not increase the steady-state mRNA expression of TGF-alpha or EGFR as assessed by northern blot analysis. Based on these in vitro findings, we postulate that the ulcer healing effect of these H2 antagonists in vivo might be due in part to stimulation of gastric mucosal cell proliferation.
Ciacci
C
C
Gastrointestinal Unit, Federico II University Medical School, Naples, Italy.
Zarrilli
R
R
Ricci
V
V
De Luca
A
A
Mazzacca
G
G
Del Vecchio Blanco
C
C
Romano
M
M
D000230:Adenocarcinoma / Q000473:pathology; D015152:Blotting, Northern; D002455:Cell Division / Q000187:drug effects; D002465:Cell Movement / Q000187:drug effects; D004305:Dose-Response Relationship, Drug; D066246:ErbB Receptors / Q000187:drug effects; D005753:Gastric Mucosa / Q000166:cytology / Q000187:drug effects*; D006635:Histamine H2 Antagonists / Q000494:pharmacology*; D006801:Humans; D010880:Piperidines / Q000494:pharmacology*; D012333:RNA, Messenger / Q000032:analysis / Q000187:drug effects; D012334:RNA, Neoplasm / Q000032:analysis / Q000187:drug effects; D011899:Ranitidine / Q000494:pharmacology*; D013268:Stimulation, Chemical; D013274:Stomach Neoplasms / Q000473:pathology; D013997:Time Factors; D016211:Transforming Growth Factor alpha / Q000187:drug effects / Q000494:pharmacology; D014407:Tumor Cells, Cultured
D006635:Histamine H2 Antagonists; D010880:Piperidines; D012333:RNA, Messenger; D012334:RNA, Neoplasm; D016211:Transforming Growth Factor alpha; D011899:Ranitidine; D066246:ErbB Receptors; C053742:roxatidine acetate